Prezcobix 150 mg (Cobicistat TABLET) 150 MG

PREZCOBIX 150 MG tablets contain cobicistat, a medication used to support HIV treatment. This oral tablet is manufactured by Janssen Inc. in Canada.

Strength

150 MG

Pack Size

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PREZCOBIX 150 MG is a tablet form of cobicistat, a medication often used in combination with other drugs to manage HIV. Cobicistat is not an antiviral itself but helps boost the effectiveness of certain HIV medications. It is typically prescribed as part of a broader treatment plan for HIV infection.

Side Effects

Common effects of PREZCOBIX 150 MG may include changes in liver function, as cobicistat can affect how the liver processes certain substances. Some individuals may experience mild gastrointestinal discomfort or fatigue. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

PREZCOBIX 150 MG should be handled with care, especially if you have liver issues. It is important to follow the prescribed dosage and monitor liver function regularly. Avoid alcohol and other medications that may interact with cobicistat without consulting a healthcare provider.

Avoid Interactions

PREZCOBIX 150 MG may interact with a variety of medications, including those metabolized by the liver's cytochrome P450 system. This can affect the effectiveness of other drugs you are taking. Always inform your healthcare provider about all medications you are using to avoid potential interactions.

Frequently Asked Questions

PREZCOBIX 150 MG is used in combination with other medications to manage HIV infection. It helps boost the effectiveness of certain HIV drugs.

PREZCOBIX 150 MG tablets are taken orally, typically once daily. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include changes in liver function, gastrointestinal discomfort, and fatigue. Always consult a healthcare provider for personalized advice.

It is generally advised to avoid alcohol while taking PREZCOBIX 150 MG, as it may interact with the medication and affect liver function.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.